Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Verbon

Showing results (11-20 of 86) with videos related to

Pageof 9
Sort By:
HIV Medicine|April 18, 2014
Successful switch to rilpivirine/tenofovir/emtricitabine in HIV-1-infected patients with an isolated K103N mutation acquired during prior nonnucleoside reverse transcriptase inhibitor therapyC Rokx, A Verbon, B J A Rijnders
Clinical and Experimental Immunology|September 1, 1992
Characterization of B cell epitopes on the 16K antigen of Mycobacterium tuberculosisA Verbon, R A Hartskeerl, C Moreno, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 9, 2019
Use of other antimicrobial drugs is associated with trimethoprim resistance in patients with urinary tract infections caused by E. coliM Mulder, A Verbon, J Lous, et al.
BMC Primary Care|September 7, 2022
Adherence to and usefulness of the national treatment guideline for urinary tract infections (UTI) in a risk areaA A van Driel, M Mulder, E E Stobberingh, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 8, 2019
Differentiation between Streptococcus pneumoniae and other viridans group streptococci by matrix-assisted laser desorption/ionization time of flight mass spectrometryR Y Yahiaoui, W H Goessens, E E Stobberingh, et al.
Scandinavian Journal of Immunology|September 1, 1992
Antibodies against secreted and non-secreted antigens in mice after infection with live Mycobacterium tuberculosisA Verbon, S Kuijper, H M Jansen, et al.
The Netherlands Journal of Medicine|December 9, 2017
Ending the epidemic: Critical role of primary HIV infectionH A B Prins, A Verbon, C A B Boucher, et al.
Nederlands Tijdschrift Voor Geneeskunde|January 26, 1991
[Development of a serological test for tuberculosis]A Verbon, S Kuijper, H M Jansen, et al.
HIV Medicine|February 5, 2016
Virological responses to lamivudine or emtricitabine when combined with tenofovir and a protease inhibitor in treatment-naïve HIV-1-infected patients in the Dutch AIDS Therapy Evaluation in the Netherlands (ATHENA) cohortC Rokx, L Gras, Damc van de Vijver, et al.
Journal of General Microbiology|May 1, 1990
Antigens in culture supernatant of Mycobacterium tuberculosis: epitopes defined by monoclonal and human antibodiesA Verbon, S Kuijper, H M Jansen, et al.
Pageof 9

Showing results (11-20 of 86) with videos related to

Sort By:
Pageof 9
HIV Medicine|April 18, 2014
Successful switch to rilpivirine/tenofovir/emtricitabine in HIV-1-infected patients with an isolated K103N mutation acquired during prior nonnucleoside reverse transcriptase inhibitor therapyC Rokx, A Verbon, B J A Rijnders
Clinical and Experimental Immunology|September 1, 1992
Characterization of B cell epitopes on the 16K antigen of Mycobacterium tuberculosisA Verbon, R A Hartskeerl, C Moreno, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 9, 2019
Use of other antimicrobial drugs is associated with trimethoprim resistance in patients with urinary tract infections caused by E. coliM Mulder, A Verbon, J Lous, et al.
BMC Primary Care|September 7, 2022
Adherence to and usefulness of the national treatment guideline for urinary tract infections (UTI) in a risk areaA A van Driel, M Mulder, E E Stobberingh, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 8, 2019
Differentiation between Streptococcus pneumoniae and other viridans group streptococci by matrix-assisted laser desorption/ionization time of flight mass spectrometryR Y Yahiaoui, W H Goessens, E E Stobberingh, et al.
Scandinavian Journal of Immunology|September 1, 1992
Antibodies against secreted and non-secreted antigens in mice after infection with live Mycobacterium tuberculosisA Verbon, S Kuijper, H M Jansen, et al.
The Netherlands Journal of Medicine|December 9, 2017
Ending the epidemic: Critical role of primary HIV infectionH A B Prins, A Verbon, C A B Boucher, et al.
Nederlands Tijdschrift Voor Geneeskunde|January 26, 1991
[Development of a serological test for tuberculosis]A Verbon, S Kuijper, H M Jansen, et al.
HIV Medicine|February 5, 2016
Virological responses to lamivudine or emtricitabine when combined with tenofovir and a protease inhibitor in treatment-naïve HIV-1-infected patients in the Dutch AIDS Therapy Evaluation in the Netherlands (ATHENA) cohortC Rokx, L Gras, Damc van de Vijver, et al.
Journal of General Microbiology|May 1, 1990
Antigens in culture supernatant of Mycobacterium tuberculosis: epitopes defined by monoclonal and human antibodiesA Verbon, S Kuijper, H M Jansen, et al.
Pageof 9